CompuGroup Medical SE KGaA Management
Management criteria checks 2/4
CompuGroup Medical SE KGaA's CEO is Michael Rauch, appointed in Aug 2019, has a tenure of 4.75 years. total yearly compensation is €6.63M, comprised of 9.2% salary and 90.8% bonuses, including company stock and options. directly owns 0.021% of the company’s shares, worth €309.34K. The average tenure of the management team and the board of directors is 3.8 years and 3.3 years respectively.
Key information
Michael Rauch
Chief executive officer
€6.6m
Total compensation
| CEO salary percentage | 9.2% |
| CEO tenure | 4.8yrs |
| CEO ownership | 0.02% |
| Management average tenure | 3.8yrs |
| Board average tenure | 3.3yrs |
Recent management updates
Recent updates
CompuGroup Medical SE KGaA (ETR:COP) Will Pay A Larger Dividend Than Last Year At €1.00
Apr 27
CompuGroup Medical SE KGaA's (ETR:COP) Upcoming Dividend Will Be Larger Than Last Year's
Apr 12We Think CompuGroup Medical SE KGaA (ETR:COP) Can Stay On Top Of Its Debt
Mar 20CompuGroup Medical SE & Co. KGaA (ETR:COP) Shares Could Be 49% Below Their Intrinsic Value Estimate
Feb 08Investors Interested In CompuGroup Medical SE & Co. KGaA's (ETR:COP) Earnings
Jan 25Is It Time To Consider Buying CompuGroup Medical SE & Co. KGaA (ETR:COP)?
Jan 12The Returns On Capital At CompuGroup Medical SE KGaA (ETR:COP) Don't Inspire Confidence
Dec 28We Think CompuGroup Medical SE KGaA (ETR:COP) Can Stay On Top Of Its Debt
Dec 15Is CompuGroup Medical SE & Co. KGaA (ETR:COP) Potentially Undervalued?
Oct 09CompuGroup Medical SE KGaA (ETR:COP) Could Be Struggling To Allocate Capital
Sep 22Do CompuGroup Medical SE KGaA's (ETR:COP) Earnings Warrant Your Attention?
Sep 07Is CompuGroup Medical SE & Co. KGaA (ETR:COP) Trading At A 33% Discount?
Aug 23Here's Why CompuGroup Medical SE KGaA (ETR:COP) Can Manage Its Debt Responsibly
Jul 13At €46.82, Is CompuGroup Medical SE & Co. KGaA (ETR:COP) Worth Looking At Closely?
Jun 24CompuGroup Medical SE KGaA (ETR:COP) Is Reinvesting At Lower Rates Of Return
May 27CompuGroup Medical SE KGaA (ETR:COP) Has Announced A Dividend Of €0.50
May 11Is CompuGroup Medical SE & Co. KGaA (ETR:COP) Trading At A 32% Discount?
May 06We Think CompuGroup Medical SE KGaA (ETR:COP) Can Stay On Top Of Its Debt
Apr 06What Does CompuGroup Medical SE & Co. KGaA's (ETR:COP) Share Price Indicate?
Mar 07Be Wary Of CompuGroup Medical SE KGaA (ETR:COP) And Its Returns On Capital
Feb 06An Intrinsic Calculation For CompuGroup Medical SE & Co. KGaA (ETR:COP) Suggests It's 28% Undervalued
Jan 21These 4 Measures Indicate That CompuGroup Medical SE KGaA (ETR:COP) Is Using Debt Reasonably Well
Jan 05Is Now An Opportune Moment To Examine CompuGroup Medical SE & Co. KGaA (ETR:COP)?
Dec 06CompuGroup Medical SE KGaA (ETR:COP) May Have Issues Allocating Its Capital
Oct 27Are Investors Undervaluing CompuGroup Medical SE & Co. KGaA (ETR:COP) By 49%?
Oct 12At €39.20, Is It Time To Put CompuGroup Medical SE & Co. KGaA (ETR:COP) On Your Watch List?
Sep 04CompuGroup Medical SE KGaA (ETR:COP) Has A Pretty Healthy Balance Sheet
Aug 04Here's What's Concerning About CompuGroup Medical SE KGaA's (ETR:COP) Returns On Capital
Jul 16When Should You Buy CompuGroup Medical SE & Co. KGaA (ETR:COP)?
May 31CompuGroup Medical SE KGaA (ETR:COP) Has Announced A Dividend Of €0.50
May 11CompuGroup Medical SE KGaA (ETR:COP) Will Pay A Dividend Of €0.50
Apr 24CompuGroup Medical SE KGaA (ETR:COP) Has Announced A Dividend Of €0.50
Apr 10The Returns On Capital At CompuGroup Medical SE KGaA (ETR:COP) Don't Inspire Confidence
Mar 31What Does CompuGroup Medical SE & Co. KGaA's (ETR:COP) Share Price Indicate?
Feb 25CompuGroup Medical SE KGaA (ETR:COP) Has A Pretty Healthy Balance Sheet
Jan 26CompuGroup Medical SE KGaA (ETR:COP) Will Be Hoping To Turn Its Returns On Capital Around
Dec 21When Should You Buy CompuGroup Medical SE & Co. KGaA (ETR:COP)?
Nov 16CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Dec 31 2023 | n/a | n/a | €46m |
| Sep 30 2023 | n/a | n/a | €76m |
| Jun 30 2023 | n/a | n/a | €89m |
| Mar 31 2023 | n/a | n/a | €70m |
| Dec 31 2022 | €7m | €613k | €73m |
| Sep 30 2022 | n/a | n/a | €72m |
| Jun 30 2022 | n/a | n/a | €71m |
| Mar 31 2022 | n/a | n/a | €76m |
| Dec 31 2021 | €966k | €425k | €69m |
| Sep 30 2021 | n/a | n/a | €66m |
| Jun 30 2021 | n/a | n/a | €72m |
| Mar 31 2021 | n/a | n/a | €71m |
| Dec 31 2020 | €1m | €425k | €73m |
| Sep 30 2020 | n/a | n/a | €77m |
| Jun 30 2020 | n/a | n/a | €60m |
| Mar 31 2020 | n/a | n/a | €58m |
| Dec 31 2019 | €666k | €177k | €66m |
Compensation vs Market: Michael's total compensation ($USD7.08M) is above average for companies of similar size in the German market ($USD1.61M).
Compensation vs Earnings: Michael's compensation has increased by more than 20% whilst company earnings have fallen more than 20% in the past year.
CEO
Michael Rauch (51 yo)
4.8yrs
Tenure
€6,633,000
Compensation
Mr. Michael Rauch, MBA, LL M serves as Member of Management Board at CompuGroup Medical SE & Co. KGaA (formerly known as CompuGroup Medical Societas Europaea) since August 1, 2019 and serves as Managing Di...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO, MD & Member of Management Board | 4.8yrs | €6.63m | 0.021% € 309.3k | |
| MD of Impatient & Social Care and Member of the Management Board | 5.5yrs | €2.91m | 0.0077% € 112.5k | |
| MD of Ambulatory Information Systems Europe & Member of Management Board | 2.5yrs | €2.80m | 0.0013% € 19.7k | |
| Chief Financial Officer | less than a year | no data | no data | |
| MD of Ambulatory Information Systems DACH & Member of the Management Board | less than a year | no data | 0.00057% € 8.4k | |
| Member of Administrative Board - CompuGroup Medical Management SE | 3.8yrs | no data | 0.0015% € 22.5k | |
| Corporate Vice President of Investor Relations | no data | no data | no data | |
| Head of Corporate & Co-Head of Brand Communications | no data | no data | no data | |
| Senior Vice President of Connectivity | 4.3yrs | no data | no data |
3.8yrs
Average Tenure
51yo
Average Age
Experienced Management: COP's management team is considered experienced (3.8 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Chairman of Supervisory Board | 3.9yrs | €100.00k | no data | |
| Member of Medical Advisory Board | no data | no data | no data | |
| Independent Member of Supervisory Board | 3.9yrs | €40.00k | no data | |
| Member of Supervisory Board | 3.9yrs | €40.00k | no data | |
| Member of Supervisory Board | 3.9yrs | €60.00k | 0.0025% € 36.6k | |
| Member of Supervisory Board | 3.9yrs | €40.00k | 0.015% € 225.0k | |
| Employee Representative Member of Supervisory Board | 2.7yrs | €50.00k | no data | |
| Employee Representative Member of Supervisory Board | 2.7yrs | €40.00k | 0.000070% € 1.0k | |
| Employee Representative Member of Supervisory Board | 2.7yrs | €50.00k | no data | |
| Employee Representative Member of Supervisory Board | 2.7yrs | €50.00k | no data | |
| Vice Chairman of the Supervisory Board | 2.7yrs | €60.00k | 0.000050% € 734.4 | |
| Employee Representative Member of Supervisory Board | 3.3yrs | €40.00k | no data |
3.3yrs
Average Tenure
54yo
Average Age
Experienced Board: COP's board of directors are considered experienced (3.3 years average tenure).